Banks - Regional
Compare Stocks
5 / 10Stock Comparison
CBAN vs SBCF vs HOMB vs SFBS vs HBCP
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
CBAN vs SBCF vs HOMB vs SFBS vs HBCP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $369M | $3.06B | $5.32B | $4.35B | $504M |
| Revenue (TTM) | $186M | $870M | $1.45B | $1.02B | $209M |
| Net Income (TTM) | $28M | $145M | $458M | $277M | $46M |
| Gross Margin | 66.4% | 61.6% | 65.6% | 51.8% | 70.5% |
| Operating Margin | 18.9% | 21.4% | 36.0% | 33.6% | 27.7% |
| Forward P/E | 10.0x | 12.5x | 10.9x | 12.5x | 10.9x |
| Total Debt | $268M | $1.34B | $1.20B | $1.51B | $58M |
| Cash & Equiv. | $27M | $181M | $910M | $95M | $142M |
CBAN vs SBCF vs HOMB vs SFBS vs HBCP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Colony Bankcorp, In… (CBAN) | 100 | 155.0 | +55.0% |
| Seacoast Banking Co… (SBCF) | 100 | 144.2 | +44.2% |
| Home Bancshares, In… (HOMB) | 100 | 186.8 | +86.8% |
| ServisFirst Bancsha… (SFBS) | 100 | 228.4 | +128.4% |
| Home Bancorp, Inc. (HBCP) | 100 | 271.1 | +171.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBAN vs SBCF vs HOMB vs SFBS vs HBCP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBAN ranks third and is worth considering specifically for value.
- Lower P/E (10.0x vs 12.5x)
SBCF is the clearest fit if your priority is momentum.
- +32.2% vs HOMB's -1.3%
HOMB carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 21 yrs, beta 0.82, yield 2.8%
- Rev growth 9.5%, EPS growth 3.6%
- Lower volatility, beta 0.82, Low D/E 30.4%, current ratio 0.16x
- Beta 0.82, yield 2.8%, current ratio 0.16x
SFBS is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.2% vs CBAN's 0.5% (lower = leaner)
- Efficiency ratio 0.2% vs CBAN's 0.5%
HBCP is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 159.8% 10Y total return vs SFBS's 254.7%
- PEG 0.70 vs SBCF's 6.69
- NIM 3.8% vs CBAN's 2.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.5% NII/revenue growth vs SFBS's 4.1% | |
| Value | Lower P/E (10.0x vs 12.5x) | |
| Quality / Margins | Efficiency ratio 0.2% vs CBAN's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.82 vs SFBS's 1.23, lower leverage | |
| Dividends | 2.8% yield, 21-year raise streak, vs CBAN's 2.3%, (1 stock pays no dividend) | |
| Momentum (1Y) | +32.2% vs HOMB's -1.3% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs CBAN's 0.5% |
CBAN vs SBCF vs HOMB vs SFBS vs HBCP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBAN vs SBCF vs HOMB vs SFBS vs HBCP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HOMB leads in 2 of 6 categories
HBCP leads 2 • CBAN leads 0 • SBCF leads 0 • SFBS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HOMB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
HOMB is the larger business by revenue, generating $1.5B annually — 7.8x CBAN's $186M. HOMB is the more profitable business, keeping 27.7% of every revenue dollar as net income compared to CBAN's 15.2%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $186M | $870M | $1.5B | $1.0B | $209M |
| EBITDAEarnings before interest/tax | $42M | $202M | $601M | $346M | $60M |
| Net IncomeAfter-tax profit | $28M | $145M | $458M | $277M | $46M |
| Free Cash FlowCash after capex | $9M | $179M | $354M | $256M | $44M |
| Gross MarginGross profit ÷ Revenue | +66.4% | +61.6% | +65.6% | +51.8% | +70.5% |
| Operating MarginEBIT ÷ Revenue | +18.9% | +21.4% | +36.0% | +33.6% | +27.7% |
| Net MarginNet income ÷ Revenue | +15.2% | +16.7% | +27.7% | +27.2% | +22.0% |
| FCF MarginFCF ÷ Revenue | -3.7% | +20.6% | +29.1% | — | +21.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | -27.5% | +26.0% | +32.8% | +20.7% |
Valuation Metrics
HBCP leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.0x trailing earnings, HBCP trades at a 45% valuation discount to SBCF's 19.8x P/E. Adjusting for growth (PEG ratio), HBCP offers better value at 0.71x vs SBCF's 10.60x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $369M | $3.1B | $5.3B | $4.4B | $504M |
| Enterprise ValueMkt cap + debt − cash | $610M | $4.2B | $5.6B | $5.8B | $420M |
| Trailing P/EPrice ÷ TTM EPS | 12.40x | 19.85x | 13.45x | 15.75x | 10.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.04x | 12.54x | 10.89x | 12.47x | 10.91x |
| PEG RatioP/E ÷ EPS growth rate | 2.43x | 10.60x | 4.42x | 1.56x | 0.71x |
| EV / EBITDAEnterprise value multiple | 17.33x | 22.62x | 10.18x | 16.85x | 7.25x |
| Price / SalesMarket cap ÷ Revenue | 1.98x | 3.52x | 3.67x | 4.28x | 2.41x |
| Price / BookPrice ÷ Book value/share | 0.93x | 0.94x | 1.37x | 2.35x | 1.16x |
| Price / FCFMarket cap ÷ FCF | — | 17.12x | 12.61x | — | 11.37x |
Profitability & Efficiency
HBCP leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SFBS delivers a 14.9% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $6 for SBCF. HBCP carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to SFBS's 0.81x. On the Piotroski fundamental quality scale (0–9), HBCP scores 9/9 vs SBCF's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.0% | +5.8% | +10.9% | +14.9% | +11.0% |
| ROA (TTM)Return on assets | +0.9% | +0.8% | +2.0% | +1.6% | +1.3% |
| ROICReturn on invested capital | +4.5% | +3.9% | +7.2% | +7.3% | +7.7% |
| ROCEReturn on capital employed | +1.7% | +3.7% | +9.8% | +4.5% | +5.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 7 | 6 | 9 |
| Debt / EquityFinancial leverage | 0.71x | 0.44x | 0.30x | 0.81x | 0.13x |
| Net DebtTotal debt minus cash | $241M | $1.2B | $292M | $1.4B | -$84M |
| Cash & Equiv.Liquid assets | $27M | $181M | $910M | $95M | $142M |
| Total DebtShort + long-term debt | $268M | $1.3B | $1.2B | $1.5B | $58M |
| Interest CoverageEBIT ÷ Interest expense | 0.63x | 0.66x | 1.44x | 0.75x | 0.96x |
Total Returns (Dividends Reinvested)
Evenly matched — CBAN and HBCP each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HBCP five years ago would be worth $17,969 today (with dividends reinvested), compared to $8,951 for SBCF. Over the past 12 months, SBCF leads with a +32.2% total return vs HOMB's -1.3%. The 3-year compound annual growth rate (CAGR) favors CBAN at 33.5% vs HOMB's 12.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.7% | -0.2% | -2.4% | +12.0% | +13.2% |
| 1-Year ReturnPast 12 months | +30.1% | +32.2% | -1.3% | +10.5% | +32.1% |
| 3-Year ReturnCumulative with dividends | +137.9% | +69.1% | +42.8% | +79.1% | +130.2% |
| 5-Year ReturnCumulative with dividends | +35.4% | -10.5% | +7.6% | +27.7% | +79.7% |
| 10-Year ReturnCumulative with dividends | +144.5% | +122.1% | +58.1% | +254.7% | +159.8% |
| CAGR (3Y)Annualised 3-year return | +33.5% | +19.1% | +12.6% | +21.4% | +32.0% |
Risk & Volatility
Evenly matched — HOMB and HBCP each lead in 1 of 2 comparable metrics.
Risk & Volatility
HOMB is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than SFBS's 1.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HBCP currently trades 97.6% from its 52-week high vs HOMB's 87.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.91x | 1.19x | 0.82x | 1.23x | 0.83x |
| 52-Week HighHighest price in past year | $21.61 | $35.55 | $30.83 | $90.64 | $65.99 |
| 52-Week LowLowest price in past year | $14.63 | $23.17 | $25.68 | $67.20 | $47.96 |
| % of 52W HighCurrent price vs 52-week peak | +91.3% | +88.2% | +87.7% | +87.9% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 42.6 | 42.6 | 45.9 | 56.1 | 57.0 |
| Avg Volume (50D)Average daily shares traded | 259K | 737K | 1.5M | 317K | 119K |
Analyst Outlook
HOMB leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CBAN as "Hold", SBCF as "Hold", HOMB as "Hold", SFBS as "Buy", HBCP as "Buy". Consensus price targets imply 18.4% upside for HOMB (target: $32) vs -22.4% for HBCP (target: $50). For income investors, HOMB offers the higher dividend yield at 2.77% vs CBAN's 2.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $32.50 | $32.00 | $90.00 | $50.00 |
| # AnalystsCovering analysts | 2 | 16 | 19 | 6 | 3 |
| Dividend YieldAnnual dividend ÷ price | +2.3% | +2.3% | +2.8% | — | +0.1% |
| Dividend StreakConsecutive years of raises | 4 | 6 | 21 | 10 | 0 |
| Dividend / ShareAnnual DPS | $0.45 | $0.74 | $0.75 | — | $0.05 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | 0.0% | +1.6% | 0.0% | +2.8% |
HOMB leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). HBCP leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
CBAN vs SBCF vs HOMB vs SFBS vs HBCP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CBAN or SBCF or HOMB or SFBS or HBCP a better buy right now?
For growth investors, Home Bancshares, Inc.
(HOMB) is the stronger pick with 9. 5% revenue growth year-over-year, versus 4. 1% for ServisFirst Bancshares, Inc. (SFBS). Home Bancorp, Inc. (HBCP) offers the better valuation at 11. 0x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate ServisFirst Bancshares, Inc. (SFBS) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBAN or SBCF or HOMB or SFBS or HBCP?
On trailing P/E, Home Bancorp, Inc.
(HBCP) is the cheapest at 11. 0x versus Seacoast Banking Corporation of Florida at 19. 8x. On forward P/E, Colony Bankcorp, Inc. is actually cheaper at 10. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Home Bancorp, Inc. wins at 0. 70x versus Seacoast Banking Corporation of Florida's 6. 69x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CBAN or SBCF or HOMB or SFBS or HBCP?
Over the past 5 years, Home Bancorp, Inc.
(HBCP) delivered a total return of +79. 7%, compared to -10. 5% for Seacoast Banking Corporation of Florida (SBCF). Over 10 years, the gap is even starker: SFBS returned +254. 7% versus HOMB's +58. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBAN or SBCF or HOMB or SFBS or HBCP?
By beta (market sensitivity over 5 years), Home Bancshares, Inc.
(HOMB) is the lower-risk stock at 0. 82β versus ServisFirst Bancshares, Inc. 's 1. 23β — meaning SFBS is approximately 50% more volatile than HOMB relative to the S&P 500. On balance sheet safety, Home Bancorp, Inc. (HBCP) carries a lower debt/equity ratio of 13% versus 81% for ServisFirst Bancshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CBAN or SBCF or HOMB or SFBS or HBCP?
By revenue growth (latest reported year), Home Bancshares, Inc.
(HOMB) is pulling ahead at 9. 5% versus 4. 1% for ServisFirst Bancshares, Inc. (SFBS). On earnings-per-share growth, the picture is similar: Home Bancorp, Inc. grew EPS 28. 4% year-over-year, compared to 3. 6% for Home Bancshares, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBAN or SBCF or HOMB or SFBS or HBCP?
Home Bancshares, Inc.
(HOMB) is the more profitable company, earning 27. 7% net margin versus 15. 2% for Colony Bankcorp, Inc. — meaning it keeps 27. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOMB leads at 36. 0% versus 18. 9% for CBAN. At the gross margin level — before operating expenses — HBCP leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBAN or SBCF or HOMB or SFBS or HBCP more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Home Bancorp, Inc. (HBCP) is the more undervalued stock at a PEG of 0. 70x versus Seacoast Banking Corporation of Florida's 6. 69x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Colony Bankcorp, Inc. (CBAN) trades at 10. 0x forward P/E versus 12. 5x for Seacoast Banking Corporation of Florida — 2. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HOMB: 18. 4% to $32. 00.
08Which pays a better dividend — CBAN or SBCF or HOMB or SFBS or HBCP?
In this comparison, HOMB (2.
8% yield), SBCF (2. 3% yield), CBAN (2. 3% yield) pay a dividend. SFBS, HBCP do not pay a meaningful dividend and should not be held primarily for income.
09Is CBAN or SBCF or HOMB or SFBS or HBCP better for a retirement portfolio?
For long-horizon retirement investors, Home Bancshares, Inc.
(HOMB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 2. 8% yield). Both have compounded well over 10 years (HOMB: +58. 1%, SFBS: +254. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBAN and SBCF and HOMB and SFBS and HBCP?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CBAN is a small-cap deep-value stock; SBCF is a small-cap quality compounder stock; HOMB is a small-cap deep-value stock; SFBS is a small-cap deep-value stock; HBCP is a small-cap deep-value stock. CBAN, SBCF, HOMB pay a dividend while SFBS, HBCP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.